FDA
approval
· 2022-06-08
FDA Approved: NEOSTIGMINE METHYLSULFATE — Supplemental Application (Civica, Inc.)
Summary
The FDA approved a supplemental application for Neostigmine methylsulfate filed by Civica, Inc. This approval covers the drug under the terms of the supplementa…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)